Literature DB >> 20470849

A case-control association study of serotonin 1A receptor gene and tryptophan hydroxylase 2 gene in attention deficit hyperactivity disorder.

Se-Hoon Shim1, Young Hwangbo, Young-Joon Kwon, Hee-Yeon Jeong, Bun-Hee Lee, Jung-A Hwang, Yong-Ku Kim.   

Abstract

Serotonergic system-related genes are likely to be involved in mechanisms underlying attention deficit hyperactivity disorder (ADHD). We investigated the association of serotonin the 1A receptor C-1019G single nucleotide polymorphism (HTR1A C-1019G SNP) and tryptophan hydroxylase 2 gene -703G/T (TPH2 -703G/T) SNP with ADHD. All of the ADHD subjects completed a comprehensive and standardized diagnostic and psychological evaluation battery including the parents' Korean version of the ADHD Rating Scale-IV (ARS). The genotype and allele frequencies of 78 ADHD patients and 107 normal controls were analyzed for 5-HTR1A C-1019G and TPH2 -703G/T. There were statistically significant differences in the genotype distributions and allele frequencies of HTR1A C-1019G between the ADHD group and the control group. The homozygous allele C frequency was significantly higher in ADHD patients than in controls. However, no differences in either genotype distribution or in allele frequencies of TPH2 -703G/T were observed between the ADHD patients and the controls. In the ADHD patients, ANCOVA revealed that there were no significant differences in the subscales and total score between the ADHD probands with the CC genotype and those with the CG and GG genotypes in ARS and the Continuous Performance Test (CPT) when adjusting for age and gender. The odds ratio comparing the CC genotype group with the CG genotype group and the C allele with G was 2.12 and 1.79 respectively. Therefore, genotype CC was associated with higher risk of ADHD. Our results suggest that the HTR1A C-1019G SNP may affect susceptibility to ADHD. Further investigation with a larger number of subjects is needed in order to confirm this finding. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20470849     DOI: 10.1016/j.pnpbp.2010.05.006

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  9 in total

Review 1.  Transcriptional regulation of the 5-HT1A receptor: implications for mental illness.

Authors:  Paul R Albert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

2.  Physical exercise alleviates ADHD symptoms: regional deficits and development trajectory.

Authors:  Trevor Archer; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2011-08-18       Impact factor: 3.911

Review 3.  Pharmacogenetics of new analgesics.

Authors:  Jörn Lötsch; Gerd Geisslinger
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 4.  Association of Serotonin Receptors with Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-analysis.

Authors:  Yu-Wei Hou; Ping Xiong; Xue Gu; Xin Huang; Min Wang; Jing Wu
Journal:  Curr Med Sci       Date:  2018-06-22

Review 5.  Electrophysiological markers of genetic risk for attention deficit hyperactivity disorder.

Authors:  Charlotte Tye; Gráinne McLoughlin; Jonna Kuntsi; Philip Asherson
Journal:  Expert Rev Mol Med       Date:  2011-03-23       Impact factor: 5.600

Review 6.  Advances in molecular genetic studies of attention deficit hyperactivity disorder in China.

Authors:  Qian Gao; Lu Liu; Qiujin Qian; Yufeng Wang
Journal:  Shanghai Arch Psychiatry       Date:  2014-08

7.  Association of tryptophan hydroxylase-2 polymorphisms with oppositional defiant disorder in a Chinese Han population.

Authors:  Chang-Hong Wang; Cong Liu; En-Zhao Cong; Gai-Ling Xu; Ting-Ting Lv; Ying-Li Zhang; Qiu-Fen Ning; Ji-Kang Wang; Hui-Yao Nie; Yan Li
Journal:  Behav Brain Funct       Date:  2016-11-21       Impact factor: 3.759

8.  Transcription Factor CEBPB Inhibits the Expression of the Human HTR1A by Binding to 5' Regulatory Region in Vitro.

Authors:  Yong-Ping Liu; Xue Wu; Jing-Hua Meng; Mei Ding; Feng-Ling Xu; Jing-Jing Zhang; Jun Yao; Bao-Jie Wang
Journal:  Genes (Basel)       Date:  2019-10-12       Impact factor: 4.096

Review 9.  Attention-deficit/hyperactive disorder updates.

Authors:  Miriam Kessi; Haolin Duan; Juan Xiong; Baiyu Chen; Fang He; Lifen Yang; Yanli Ma; Olumuyiwa A Bamgbade; Jing Peng; Fei Yin
Journal:  Front Mol Neurosci       Date:  2022-09-21       Impact factor: 6.261

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.